Marc Lecomte

947 total citations
21 papers, 758 citations indexed

About

Marc Lecomte is a scholar working on Molecular Biology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marc Lecomte has authored 21 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Clinical Biochemistry and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marc Lecomte's work include Advanced Glycation End Products research (6 papers), Retinal Diseases and Treatments (4 papers) and Hormonal Regulation and Hypertension (3 papers). Marc Lecomte is often cited by papers focused on Advanced Glycation End Products research (6 papers), Retinal Diseases and Treatments (4 papers) and Hormonal Regulation and Hypertension (3 papers). Marc Lecomte collaborates with scholars based in France, Germany and United States. Marc Lecomte's co-authors include Nicolas Wiernsperger, Michel Lagarde, Daniel Ruggiero-Lopez, Daniel Ruggiero, Christophe Paget, Gerard. Moinet, William L. Smith, Dipak K. Bhattacharyya, R. Michael Garavito and Caroline Jill Rieke and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Marc Lecomte

19 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Lecomte France	12	274	212	185	164	102	21	758
Joelle M. Onorato United States	16	214 0.8×	262 1.2×	187 1.0×	103 0.6×	113 1.1×	28	790
Net Daş-Evcimen Türkiye	9	97 0.4×	245 1.2×	134 0.7×	65 0.4×	124 1.2×	15	623
Kazuharu Ienaga Japan	18	519 1.9×	457 2.2×	271 1.5×	90 0.5×	314 3.1×	71	1.5k
Mary C. Wells-Knecht United States	9	438 1.6×	352 1.7×	187 1.0×	41 0.3×	213 2.1×	9	893
Noe Gonzales United States	17	263 1.0×	534 2.5×	383 2.1×	190 1.2×	258 2.5×	21	1.2k
Sampath Parthasarathy United States	10	225 0.8×	257 1.2×	207 1.1×	87 0.5×	161 1.6×	12	1.1k
Shin Aoki Japan	18	345 1.3×	396 1.9×	726 3.9×	73 0.4×	163 1.6×	46	1.3k
Giuliana Leoncini Italy	23	178 0.6×	406 1.9×	131 0.7×	263 1.6×	311 3.0×	91	1.4k
Toshio Sada Japan	17	111 0.4×	326 1.5×	407 2.2×	71 0.4×	208 2.0×	36	1.2k
Antonio M. Pastorino Italy	15	77 0.3×	428 2.0×	140 0.8×	214 1.3×	192 1.9×	23	1.6k

Countries citing papers authored by Marc Lecomte

Since Specialization

Citations

This map shows the geographic impact of Marc Lecomte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lecomte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lecomte more than expected).

Fields of papers citing papers by Marc Lecomte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Lecomte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lecomte. The network helps show where Marc Lecomte may publish in the future.

Co-authorship network of co-authors of Marc Lecomte

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Lecomte. A scholar is included among the top collaborators of Marc Lecomte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Lecomte. Marc Lecomte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hofmann, Nicole, et al.. (2025). PROTAC Enabling Formulation In Vivo: Implications of the Polymeric Carrier Eudragit E PO. Molecular Pharmaceutics. 22(10). 5845–5859.

Maurer, Christine K., Zhizhou Fang, Christina Schindler, et al.. (2025). In vitro and in vivo ADME of heterobifunctional degraders: a tailored approach to optimize DMPK properties of PROTACs©. RSC Medicinal Chemistry. 16(4). 1746–1757. 6 indexed citations

Schiemann, Kai, Kalyan C. Nallaparaju, Carsten Boesler, et al.. (2024). Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo. Molecular Cancer Therapeutics. 23(11). 1517–1529. 6 indexed citations

Zaynagetdinov, Rinat, Kai Schiemann, Kalyan C. Nallaparaju, et al.. (2022). Abstract 3499: M1069 as dual A2A/A2B adenosine receptor antagonist counteracts immune-suppressive mechanisms of adenosine and reduces tumor growth in vivo. Cancer Research. 82(12_Supplement). 3499–3499. 7 indexed citations

Lecomte, Marc, et al.. (2020). Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human. European Journal of Pharmaceutical Sciences. 152. 105431–105431. 9 indexed citations

Wagner, Christian, Markus Weigandt, Christian Weber, et al.. (2019). Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model. Molecular Pharmaceutics. 16(9). 3938–3947. 24 indexed citations

Petersson, Carl, Orestis Papasouliotis, Marc Lecomte, Lassina Badolo, & Hugues Dolgos. (2019). Prediction of volume of distribution in humans: analysis of eight methods and their application in drug discovery. Xenobiotica. 50(3). 270–279. 12 indexed citations

Valeur, Eric, Djordje Müsil, L Doaré, et al.. (2012). Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 22(18). 5909–5914. 11 indexed citations

Roche, Didier, Caroline Leriche, L Doaré, et al.. (2009). Discovery and structure-guided drug design of inhibitors of 11β-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold. Bioorganic & Medicinal Chemistry Letters. 19(13). 3682–3685. 21 indexed citations

10.

Roche, Didier, Caroline Leriche, L Doaré, et al.. (2009). Discovery and structure–activity relationships of pentanedioic acid diamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 19(10). 2674–2678. 13 indexed citations

11.

Stassart, Pierre M & Marc Lecomte. (2006). Délibération consommateurs Projet "Boeuf" de la "Semois", nous ne désirons pas dire aux éleveurs ce qu'ils doivent faire mais nous souhaitons qu'ils écoutent ce que nous avons appris (18 p.). Open Repository and Bibliography (University of Liège).

12.

Lecomte, Marc, et al.. (2004). Involvement of caspase-10 in advanced glycation end-product-induced apoptosis of bovine retinal pericytes in culture. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1689(3). 202–211. 15 indexed citations

13.

Lecomte, Marc, et al.. (2002). Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction. Free Radical Biology and Medicine. 33(2). 236–247. 117 indexed citations

14.

Faure, Patrice, et al.. (2000). Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Research and Clinical Practice. 50. 370–370. 2 indexed citations

15.

Ruggiero-Lopez, Daniel, et al.. (1999). In vitro and in vivo alterations of enzymatic glycosylation in diabetes. Life Sciences. 64(17). 1571–1583. 37 indexed citations

16.

Ruggiero-Lopez, Daniel, et al.. (1999). Reaction of metformin with dicarbonyl compounds. possible implication in the inhibition of advanced glycation end product formation. Biochemical Pharmacology. 58(11). 1765–1773. 197 indexed citations

17.

Paget, Christophe, Marc Lecomte, Daniel Ruggiero, Nicolas Wiernsperger, & Michel Lagarde. (1998). Modification of Enzymatic Antioxidants in Retinal Microvascular Cells by Glucose or Advanced Glycation End Products. Free Radical Biology and Medicine. 25(1). 121–129. 77 indexed citations

18.

Vailhé, Bruno, Marc Lecomte, Nicolas Wiernsperger, & Léone Tranqui. (1998). The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis. 2(4). 331–344. 40 indexed citations

19.

Bhattacharyya, Dipak K., Marc Lecomte, Caroline Jill Rieke, R. Michael Garavito, & William L. Smith. (1996). Involvement of Arginine 120, Glutamate 524, and Tyrosine 355 in the Binding of Arachidonate and 2-Phenylpropionic Acid Inhibitors to the Cyclooxygenase Active Site of Ovine Prostaglandin Endoperoxide H Synthase-1. Journal of Biological Chemistry. 271(4). 2179–2184. 158 indexed citations

20.

Smith, William L., Marc Lecomte, Odette Laneuville, Debra K. Breuer, & David L. DeWitt. (1995). DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE H SYNTHASES-1 AND -2 BY ASPIRIN AND OTHER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS1. European Journal of Medicinal Chemistry. 30. 417s–427s. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact